Altered localization, abnormal modification and loss of function of sigma receptor-1 in amyotrophic lateral sclerosis

Human Molecular Genetics

Volumn 22, Issue 8, 2013, Pages 1581-1600

  Prause, J ^a   Goswami, A ^a   Katona, I ^a   Roos, A ^a   Schnizler, M ^a   Bushuven, E ^a   Dreier, A ^a   Buchkremer, S ^a   Johann, S ^a   Beyer, C ^a   Deschauer, M ^b   Troost, D ^c   Weis, J ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR 1; UNCLASSIFIED DRUG;

ALPHA NERVE FIBER; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BIOACCUMULATION; CALCIUM SIGNALING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FIBROBLAST; GOLGI COMPLEX; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; LUMBAR SPINE; MOUSE; NERVE CELL CULTURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; UPREGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CALCIUM SIGNALING; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; FRONTOTEMPORAL LOBAR DEGENERATION; LUMBAR VERTEBRAE; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; NEURONS; PROTEIN FOLDING; PROTEOLYSIS; RECEPTORS, SIGMA; SPINAL CORD; SUPEROXIDE DISMUTASE; UNFOLDED PROTEIN RESPONSE;

MUS MUSCULUS;

EID: 84875768176     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt008     Document Type: Article

References (84)

1. Sherman, M.Y. and Goldberg, A.L. (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron, 29, 15-32.
2. Taylor, J.P., Hardy, J. and Fischbeck, K.H. (2002) Toxic proteins in neurodegenerative disease. Science, 296, 1991-1995.
3. Ross, C.A. and Poirier, M.A. (2004) Protein aggregation and neurodegenerative disease. Nat. Med., 10(suppl), S10-S17.
4. Ciechanover, A. (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J., 17, 7151-7160.
5. Jana, N.R., Zemskov, E.A., Wang, G. and Nukina, N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet., 10, 1049-1059.
6. Ross, C.A. and Poirier, M.A. (2005) Opinion: what is the role of protein aggregation in neurodegeneration Nat. Rev. Mol. Cell Biol., 6, 891-898.
7. Goswami, A., Dikshit, P., Mishra, A., Mulherkar, S., Nukina, N. and Jana, N.R. (2006) Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. Biochem. Biophys. Res. Commun., 342, 184-190.
8. Jana, N.R., Tanaka, M., Wang, G. and Nukina, N. (2000) Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet., 9, 2009-2018.
9. Rosen, D.R., Sapp, P., O'Regan, J., McKenna-Yasek, D., Schlumpf, K.S., Haines, J.L., Gusella, J.F., Horvitz, H.R. and Brown, R.H. Jr. (1994) Genetic linkage analysis of familial amyotrophic lateral sclerosis using human chromosome 21 microsatellite DNA markers. Am. J. Med. Genet., 51, 61-69.
10. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H.X. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
11. Daoud, H., Valdmanis, P.N., Kabashi, E., Dion, P., Dupre, N., Camu, W., Meininger, V. and Rouleau, G.A. (2009) Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J. Med. Genet., 46, 112-114.
12. Valdmanis, P.N., Daoud, H., Dion, P.A. and Rouleau, G.A. (2009) Recent advances in the genetics of amyotrophic lateral sclerosis. Curr. Neurol. Neurosci. Rep., 9, 198-205.
13. Kanekura, K., Nishimoto, I., Aiso, S. and Matsuoka, M. (2006) Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J. Biol. Chem., 281, 30223-30233.
14. Millecamps, S., Salachas, F., Cazeneuve, C., Gordon, P., Bricka, B., Camuzat, A., Guillot-Noel, L., Russaouen, O., Bruneteau, G., Pradat, P.F. et al. (2010) SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J. Med. Genet., 47, 554-560.
15. Luty, A.A., Kwok, J.B., Dobson-Stone, C., Loy, C.T., Coupland, K.G., Karlstrom, H., Sobow, T., Tchorzewska, J., Maruszak, A., Barcikowska, M. et al. (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann. Neurol., 68, 639-649.
16. Al-Saif, A., Al-Mohanna, F. and Bohlega, S. (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol., 70, 913-919.
17. Quirion, R., Bowen, W.D., Itzhak, Y., Junien, J.L., Musacchio, J.M., Rothman, R.B., Su, T.P., Tam, S.W. and Taylor, D.P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci., 13, 85-86.
18. Hanner, M., Moebius, F.F., Flandorfer, A., Knaus, H.G., Striessnig, J., Kempner, E. and Glossmann, H. (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl Acad. Sci. USA, 93, 8072-8077.
19. Su, T.P., London, E.D. and Jaffe, J.H. (1988) Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science, 240, 219-221.
20. Maurice, T. and Lockhart, B.P. (1997) Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands. Prog. Neuropsychopharmacol. Biol. Psychiatry, 21, 69-102.
21. Hayashi, T., Maurice, T. and Su, T.P. (2000) Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J. Pharmacol. Exp. Ther., 293, 788-798.
22. Hayashi, T. and Su, T.P. (2005) The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci., 77, 1612-1624.
23. Lipton, S.A. and Rosenberg, P.A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med., 330, 613-622.
24. Goyagi, T., Goto, S., Bhardwaj, A., Dawson, V.L., Hurn, P.D. and Kirsch, J.R. (2001) Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke, 32, 1613-1620.
25. Goyagi, T., Bhardwaj, A., Koehler, R.C., Traystman, R.J., Hurn, P.D. and Kirsch, J.R. (2003) Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenyl butyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. Anesth. Analg., 96, 532-538, table of contents.
26. Villegas, J. and McPhaul, M. (2005) Establishment and culture of human skin fibroblasts. Curr. Protoc. Mol. Biol., Chapter 28, Unit 28.3.
27. Guzman-Lenis, M.S., Navarro, X. and Casas, C. (2009) Selective sigma receptor agonist 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate (PRE084) promotes neuroprotection and neurite elongation through protein kinase C (PKC) signaling on motoneurons. Neuroscience, 162, 31-38.
28. Pal, A., Fontanilla, D., Gopalakrishnan, A., Chae, Y.K., Markley, J.L. and Ruoho, A.E. (2012) The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. Eur. J. Pharmacol., 682, 12-20.
29. Niitsu, T., Iyo, M. and Hashimoto, K. (2012) Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. Curr. Pharm. Des., 18, 875-883.
30. Mavlyutov, T.A., Epstein, M.L., Andersen, K.A., Ziskind-Conhaim, L. and Ruoho, A.E. (2010) The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience, 167, 247-255.
31. Wang, L. and Duncan, G. (2006) Silencing of sigma-1 receptor induces cell death in human lens cells. Exp. Cell Res., 312, 1439-1446.
32. Tchedre, K.T. and Yorio, T. (2008) sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation. Invest. Ophthalmol. Vis. Sci., 49, 2577-2588.
33. Nishimura, A.L., Al-Chalabi, A. and Zatz, M. (2005) A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum. Genet., 118, 499-500.
34. Funke, A.D., Esser, M., Kruttgen, A., Weis, J., Mitne-Neto, M., Lazar, M., Nishimura, A.L., Sperfeld, A.D., Trillenberg, P., Senderek, J. et al. (2010) The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin. Genet., 77, 302-303.
35. Lagier-Tourenne, C. and Cleveland, D.W. (2009) Rethinking ALS: the FUS about TDP-43. Cell, 136, 1001-1004.
36. Wood, J.D., Beaujeux, T.P. and Shaw, P.J. (2003) Protein aggregation in motor neurone disorders. Neuropathol. Appl. Neurobiol., 29, 529-545.
37. Nagy, J.I., Yamamoto, T. and Jordan, L.M. (1993) Evidence for the cholinergic nature of C-terminals associated with subsurface cisterns in alpha-motoneurons of rat. Synapse, 15, 17-32.
38. Mishina, M., Ishiwata, K., Ishii, K., Kitamura, S., Kimura, Y., Kawamura, K., Oda, K., Sasaki, T., Sakayori, O., Hamamoto, M. et al. (2005) Function of sigma1 receptors in Parkinson's disease. Acta Neurol. Scand., 112, 103-107.
39. Hayashi, T. and Su, T.P. (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell, 131, 596-610.
40. Mishina, M., Ohyama, M., Ishii, K., Kitamura, S., Kimura, Y., Oda, K., Kawamura, K., Sasaki, T., Kobayashi, S., Katayama, Y. et al. (2008) Low density of sigma1 receptors in early Alzheimer's disease. Ann. Nucl. Med., 22, 151-156.
41. Toyohara, J., Sakata, M. and Ishiwata, K. (2009) Imaging of sigma1 receptors in the human brain using PET and [11C]SA4503. Centr. Nerv. Syst. Agents Med. Chem., 9, 190-196.
42. Bush, K.T., Goldberg, A.L. and Nigam, S.K. (1997) Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J. Biol. Chem., 272, 9086-9092.
43. Menendez-Benito, V., Verhoef, L.G., Masucci, M.G. and Dantuma, N.P. (2005) Endoplasmic reticulum stress compromises the ubiquitinproteasome system. Hum. Mol. Genet., 14, 2787-2799.
44. Ilieva, E.V., Ayala, V., Jove, M., Dalfo, E., Cacabelos, D., Povedano, M., Bellmunt, M.J., Ferrer, I., Pamplona, R. and Portero-Otin, M. (2007) Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain, 130, 3111-3123.
45. Walker, A.K. and Atkin, J.D. (2011) Stress signaling from the endoplasmic reticulum: a central player in the pathogenesis of amyotrophic lateral sclerosis. IUBMB Life, 63, 754-763.
46. Kikuchi, H., Almer, G., Yamashita, S., Guegan, C., Nagai, M., Xu, Z., Sosunov, A.A., McKhann, G.M. II and Przedborski, S. (2006) Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl Acad. Sci. USA, 103, 6025-6030.
47. Mizushima, N., Ohsumi, Y. and Yoshimori, T. (2002) Autophagosome formation in mammalian cells. Cell Struct. Funct., 27, 421-429.
48. He, C. and Klionsky, D.J. (2009) Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet., 43, 67-93.
49. Glickman, M.H. and Ciechanover, A. (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev., 82, 373-428.
50. Dikshit, P., Goswami, A., Mishra, A., Nukina, N. and Jana, N.R. (2006) Curcumin enhances the polyglutamine-expanded truncated N-terminal huntingtin-induced cell death by promoting proteasomal malfunction. Biochem. Biophys. Res. Commun., 342, 1323-1328.
51. Drexler, H.C. (1997) Activation of the cell death program by inhibition of proteasome function. Proc. Natl Acad. Sci. USA, 94, 855-860.
52. Hayashi, T., Rizzuto, R., Hajnoczky, G. and Su, T.P. (2009) MAM: more than just a housekeeper. Trends Cell Biol., 19, 81-88.
53. Usachev, Y., Shmigol, A., Pronchuk, N., Kostyuk, P. and Verkhratsky, A. (1993) Caffeine-induced calcium release from internal stores in cultured rat sensory neurons. Neuroscience, 57, 845-859.
54. Kirichok, Y., Krapivinsky, G. and Clapham, D.E. (2004) The mitochondrial calcium uniporter is a highly selective ion channel. Nature, 427, 360-364.
55. Zhang, D. and Armstrong, J.S. (2007) Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis. Cell Death Differ., 14, 703-715.
56. Dreier, A., Barth, S., Goswami, A. and Weis, J. (2012) Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance. Tumour Biol., 33, 85-94.
57. Orrenius, S., Zhivotovsky, B. and Nicotera, P. (2003) Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol., 4, 552-565.
58. Shioda, N., Ishikawa, K., Tagashira, H., Ishizuka, T., Yawo, H. and Fukunaga, K. (2012) Expression of a truncated form of the endoplasmic reticulum chaperone protein, sigma-1 receptor, promotes mitochondrial energy depletion and apoptosis. J. Biol. Chem., 287, 23318-23331.
59. Mancuso, R., Olivan, S., Rando, A., Casas, C., Osta, R. and Navarro, X. (2012) Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurotherapeutics, 9, 814-826.
60. Huang, Y., Zheng, L., Halliday, G., Dobson-Stone, C., Wang, Y., Tang, H.D., Cao, L., Deng, Y.L., Wang, G., Zhang, Y.M. et al. (2011) Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease. Curr. Alzheimer Res., 8, 765-770.
61. Maruszak, A., Safranow, K., Gacia, M., Gabryelewicz, T., Slowik, A., Styczynska, M., Peplonska, B., Golan, M.P., Zekanowski, C. and Barcikowska, M. (2007) Sigma receptor type 1 gene variation ina groupof Polish patients with Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord., 23, 432-438.
62. Uchida, N., Ujike, H., Tanaka, Y., Sakai, A., Yamamoto, M., Fujisawa, Y., Kanzaki, A. and Kuroda, S. (2005) A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease. Am. J. Geriatr. Psychiatry, 13, 1062-1066.
63. Harukuni, I., Bhardwaj, A., Shaivitz, A.B., DeVries, A.C., London, E.D., Hurn, P.D., Traystman, R.J., Kirsch, J.R. and Faraci, F.M. (2000) Sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke, 31, 976-982.
64. Marrazzo, A., Caraci, F., Salinaro, E.T., Su, T.P., Copani, A. and Ronsisvalle, G. (2005) Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity. Neuroreport, 16, 1223-1226.
65. Pullen, A.H. (1992) Presynaptic terminal loss from alpha-motoneurones following the retrograde axonal transport of diphtheria toxin. Acta Neuropathol., 83, 488-498.
66. Pullen, A.H. and Athanasiou, D. (2009) Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur. J. Neurosci., 29, 551-561.
67. Julien, J.P. (2001) Amyotrophic lateral sclerosis. Unfolding the toxicity of the misfolded. Cell, 104, 581-591.
68. Voisine, C., Pedersen, J.S. and Morimoto, R.I. (2010) Chaperone networks: tipping the balance in protein folding diseases. Neurobiol. Dis., 40, 12-20.
69. Lautenschlaeger, J., Prell, T. and Grosskreutz, J. (2012) Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler., 13, 166-177.
70. Hayashi, T., Hayashi, E., Fujimoto, M., Sprong, H. and Su, T.P. (2012) The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones. J. Biol. Chem., 287, 43156-43169.
71. Suzuki, H., Kanekura, K., Levine, T.P., Kohno, K., Olkkonen, V.M., Aiso, S. and Matsuoka, M. (2009) ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem., 108, 973-985.
72. Chen, H.J., Anagnostou, G., Chai, A., Withers, J., Morris, A., Adhikaree, J., Pennetta, G. and de Belleroche, J.S. (2010) Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem., 285, 40266-40281.
73. Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M.O., Akhmanova, A., Jaarsma, D. and Hoogenraad, C.C. (2007) Motor neuron disease-associated mutant vesicle-associated membrane proteinassociated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci., 27, 9801-9815.
74. De Vos, K.J., Morotz, G.M., Stoica, R., Tudor, E.L., Lau, K.F., Ackerley, S., Warley, A., Shaw, C.E. and Miller, C.C. (2012) VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet., 21, 1299-1311.
75. Bezprozvanny, I. (2009) Calcium signaling and neurodegenerative diseases. Trends Mol. Med., 15, 89-100.
76. Morotz, G.M., De Vos, K.J., Vagnoni, A., Ackerley, S., Shaw, C.E. and Miller, C.C. (2012) Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet., 21, 1979-1988.
77. Canova, N.K., Kmonickova, E., Martinek, J., Zidek, Z. and Farghali, H. (2007) Thapsigargin, a selective inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases, modulates nitric oxide production and cell death of primary rat hepatocytes in culture. Cell Biol. Toxicol., 23, 337-354.
78. Huang, H., Zhang, X., Li, S., Liu, N., Lian, W., McDowell, E., Zhou, P., Zhao, C., Guo, H., Zhang, C. et al. (2010) Physiological levels of ATP negatively regulate proteasome function. Cell Res., 20, 1372-1385.
79. Kim, S., Leal, S.S., Ben Halevy, D., Gomes, C.M. and Lev, S. (2010) Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. J. Biol. Chem., 285, 13839-13849.
80. Largent, B.L., Wikstrom, H., Snowman, A.M. and Snyder, S.H. (1988) Novel antipsychotic drugs share high affinity for sigma receptors. Eur. J. Pharmacol., 155, 345-347.
81. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.X. et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772-1775.
82. Nachreiner, T., Esser, M., Tenten, V., Troost, D., Weis, J. and Kruttgen, A. (2010) Novel splice variants of the amyotrophic lateral sclerosisassociated gene VAPB expressed in human tissues. Biochem. Biophys. Res. Commun., 394, 703-708.
83. Schroder, J.M., Hoheneck, M., Weis, J. and Deist, H. (1985) Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J. Neurol., 232, 83-90.
84. Dikshit, P., Chatterjee, M., Goswami, A., Mishra, A. and Jana, N.R. (2006) Aspirin induces apoptosis through the inhibition of proteasome function. J. Biol. Chem., 281, 29228-29235